Mass General Cancer Center – Trials Discussion Board › Forums › Clinical Trials › Mass General Cancer Center – Trials This topic has 0 replies, 1 voice, and was last updated 9 years, 1 month ago by gavin. Viewing 1 post (of 1 total) Author Posts June 5, 2015 at 5:44 pm #11353 gavinModerator Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma. https://targetedcancercare.massgeneral.org/My-Trial-Guide/Clinical-Trial/NCT02428855.aspx?context=/My-Trial-Guide/Diseases/Other-Cancers/IDH1/all-amino-acid-position-132-mutations A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma. https://targetedcancercare.massgeneral.org/My-Trial-Guide/Clinical-Trial/NCT02150967.aspx?context=/My-Trial-Guide/Diseases/Other-Cancers/IDH1/all-amino-acid-position-132-mutations Author Posts Viewing 1 post (of 1 total) The forum ‘Clinical Trials’ is closed to new topics and replies.